Not Signed In -
Daunorubicin |
Cerubidine |
Daunorubicin Systematic (IUPAC) name (8S,10S)-8-acetyl-10-[(2S,4S,5S,6S)- 4-amino-5-hydroxy-6-methyl-oxan- 2-yl]oxy-6,8,11-trihydroxy-1-methoxy- 9,10-dihydro-7H-tetracene-5,12-dione Identifiers CAS number 20830-81-3 ATC code L01DB02 PubChem 30323 DrugBank APRD00521 Chemical data Formula C27H29NO10 Mol. weight 527.52 g/mol 563.99 g/mol (HCl salt) Pharmacokinetic data Bioavailability ? Metabolism Hepatic Half life 26.7 hours (metabolite) Excreti ...
Wikipedia - [full article]
Daunorubicin Clinical Trials
- High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
ClinicalTrials.gov Identifier: NCT00474006 - Recruiting
Acute Myelogenous Leukemia
- Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00023777 - Active, not recruiting
Myeloid Leukemia
- Study of Zosuquidar, Daunorubicin, and Cytarabine in Patients Ages 55-75 with Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00129168 - Recruiting
Leukemia, Myeloid
- Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00085124 - Active, not recruiting
adult acute myeloid leukemia; secondary acute myeloid leukemia
- Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00004207 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
ClinicalTrials.gov Identifier: NCT00046930 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
- Cytarabine and Daunorubicin with Or Without Gemtuzumab Ozogamicin in Treating Older Patients with Acute Myeloid Leukemia Or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00121303 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004217 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
- Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003934 - Active, not recruiting
untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ...
- PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093600 - Active, not recruiting
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
- Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101153 - Recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
Lymphoma; Leukemia
- Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00268229 - Recruiting
Leukemia
- Induction Therapy Using Cytarabine, Daunorubicin, and, Optionally, Gemtuzumab Ozogamicin Followed By Consolidation Therapy With High-Dose Cytarabine and Postconsolidation Therapy With Gemtuzumab Ozogamicin Compared With No Additional Therapy in Patients W
ClinicalTrials.gov Identifier: NCT00085709 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
ClinicalTrials.gov Identifier: NCT00389428 - Recruiting
Hematologic Neoplasms
- Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
Acute Lymphoblastic Leukemia
- Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00018954 - Active, not recruiting
Lymphoma; Leukemia
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
recurrent adult acute lymphoblastic leukemia
- Phase 3 Randomized Study of Amonafide and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary AML
ClinicalTrials.gov Identifier: NCT00509912 - Recruiting
Secondary Acute Myeloid Leukemia
- Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002499 - Active, not recruiting
recurrent childhood acute lymphocytic leukemia
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003671 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00111345 - Recruiting
Myeloid Leukemia
- Combination Chemotherapy in Treating Children With Lymphoma
ClinicalTrials.gov Identifier: NCT00002590 - Active, not recruiting
stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00427414 - Not yet recruiting
Sarcoma
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00544999 - Not yet recruiting
Leukemia
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002517 - Active, not recruiting
Myeloid Leukemia; Myelodysplastic Syndromes; Refractory Anemia
- Randomized Controlled Trial to Test Efficacy of High-Dose MTX for Adult Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov Identifier: NCT00131027 - Recruiting
Acute Lymphoblastic Leukemia
- Combination Chemotherapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005793 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
- Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00003700 - Active, not recruiting
L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma
ClinicalTrials.gov Identifier: NCT00004228 - Active, not recruiting
stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
- Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00019409 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
- Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005945 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002704 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
- Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00015873 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003650 - Active, not recruiting
stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
- Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
- Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
Myeloid Leukemia; Neutropenia
- Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
- Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00002766 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ...
- Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005863 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
- Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00006363 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002925 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00061945 - Active, not recruiting
B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
- Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003423 - Active, not recruiting
stage I childhood large cell lymphoma; stage III childhood lymphoblastic lymphoma; stage III childhood large cell lymphoma; ...
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003190 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00022126 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
- Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004215 - Active, not recruiting
Anemia; adult acute poorly differentiated monocytic leukemia (M5a); adult acute myeloblastic leukemia with maturation (M2); ...
- Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002700 - Active, not recruiting
untreated adult acute lymphoblastic leukemia; stage I adult lymphoblastic lymphoma; stage III adult lymphoblastic lymphoma; ...
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003436 - Active, not recruiting
refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; childhood acute promyelocytic leukemia (M3); ...
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00103285 - Recruiting
untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00022737 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00109837 - Recruiting
L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
ClinicalTrials.gov Identifier: NCT00096135 - Recruiting
recurrent childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
- Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00124644 - Recruiting
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003728 - Recruiting
acute undifferentiated leukemia; childhood acute lymphoblastic leukemia; childhood lymphoblastic lymphoma
- Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
- Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004128 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00049517 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
ClinicalTrials.gov Identifier: NCT00005942 - Completed
Previously Treated Myelodysplastic Syndrome; recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; ...
- Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005962 - Completed
Myeloid Leukemia
- Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002785 - Completed
untreated childhood acute lymphoblastic leukemia
- Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00002985 - Completed
epidemic Kaposi's sarcoma; childhood skin cancer
- A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
ClinicalTrials.gov Identifier: NCT00002093 - Completed
Sarcoma, Kaposi; HIV Infections
- Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002756 - Completed
untreated childhood acute lymphoblastic leukemia; acute undifferentiated leukemia
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002744 - Completed
L1 childhood acute lymphocytic leukemia; L2 childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002812 - Completed
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002798 - Completed
Myeloid Leukemia; Refractory Anemia
- Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003593 - Completed
childhood acute monocytic leukemia; childhood acute myeloid leukemia and other myeloid malignancies; Chronic Myelomonocytic Leukemia; ...
- STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00015860 - Completed
recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia
- Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002691 - Completed
stage III childhood lymphoblastic lymphoma; stage III childhood large cell lymphoma; stage IV childhood large cell lymphoma; ...
- Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
ClinicalTrials.gov Identifier: NCT00070174 - Completed
childhood acute monocytic leukemia; childhood acute myeloid leukemia
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
ClinicalTrials.gov Identifier: NCT00002514 - Completed
adult acute lymphoblastic leukemia in remission
Resources
- Cerubidine (Drug Digest)
- Daunorubicin (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
